Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France

NANot yet recruitingINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

May 1, 2028

Conditions
HEPATITIS C (HCV)Hepatitis B Virus (HBV)Hepatitis DHepatocellular Carcinoma (HCC)Liver Fibrosis
Interventions
DIAGNOSTIC_TEST

Community screening for hepatitis B, C and delta in the Mongolian population living in France

"Screening will be organised in 11 centres in France, with 1 to 3 screening sessions per centre: patients will be informed of these screening sessions by the Mongolian Embassy in France, social networks and communities.~During this screening visit, Rapid Diagnostic Orientation Test (RDOT) will be carried out to screen for HBV and HCV. If the RDOT is negative for both viruses, an information on transmission and prevention of viral infection will be given.~If the RDOT is positive, confirmation of these tests by blood sampling will be organized and complementary biology (ASAT, ALAT, GGT, PAL, bilirubin total, bilirubin conjugated). If HBV RDOT positive, additional tubes will be collected for centralized analysis at the end of the study (VHD DNA, VHD genotyping, fibrotest and LCR1/2 test).~Once these confirmatory tests have been carried out, the patient will be referred to a hepatology consultation."

Trial Locations (11)

Unknown

Centre Hospitalier Annecy Genevois, Annecy

Centre Expert Hépatites Virales Aquitaine, CHU de Bordeaux, Bordeaux

CHU de Clermont Ferrand, Clermont-Ferrand

Hôpital Henri Mondor - Assistante Publique Hopitaux de Paris (APHP), Créteil

CHU Grenoble Alpes, Grenoble

CHRU Lille, Lille

Service d'Hépatologie, Institut d'hépatologie de Lyon, Hôpital Croix-Rousse, Hospices Civils de Lyon, Lyon

CHRU Rennes Pontchaillou, Rennes

CHU de Rouen, Rouen

Hôpitaux Universitaires de Strasbourg, Strasbourg

CHRU Bretonneau, Tours

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT07038863 - Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France | Biotech Hunter | Biotech Hunter